Temperature-controlled Laminar Airflow works by interrupting the body’s usual convection currents and by delivering slightly cooled, filtered air to the patient’s breathing zone whilst they are asleep at night.
TLA treatment dramatically reduces the number of allergen particles inhaled overnight allowing a period of essential recovery for the patient’s lungs.
For more information on the Airsonett® device and TLA treatment please visit www.airsonett.com
Or click here for the Airsonett® patient information brochure